Skip to content

Nasdaq · CIK 0001768446

CLYM Climb Bio, Inc.

Insider trading from SEC Form 4. Last filing 12 d ago. Close $11.00 on Oct 9, 2026, +571% from the 52-week low and -38% from the high.

Last 90 days

Net insider value
-$1.4M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$1.4M by 1 insider
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

CLYMOct 9, 2026 · close 11.00

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Climb Bio, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
25WeakStephen Basil Thomas
director
sell
$1.4M
100,000 shares
-18%-
13WeakAoife Brennan
President and CEO
sell
$25k
20,618 shares
-30%+10% from low-85% from high
0WeakEmily Pimblett
SVP, Finance & CAO
sell
$1,540
1,242 shares
-6%+7% from low-86% from high
0WeakEmily Pimblett
SVP, Finance & CAO
sell
$1,571
1,199 shares
-7%-
0WeakEmily Pimblett
CHIEF ACCOUNTING OFFICER
sell
$2,495
1,235 shares
-10%-

Transactions

The last 44 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Common Stockindirect: See footnotes
+10,000$3.46$35k10,00012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Common Stockindirect: See footnotes
+10,000$3.00$30k20,00012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Common Stockindirect: See footnotes
+10,000$7.89$79k30,00012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Common Stockindirect: See footnotes
+40,000$1.29$52k70,00012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Stock Option (Right to Buy)derivativeindirect: See footnotes
-10,000$0.00$0012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Stock Option (Right to Buy)derivativeindirect: See Footnotes
-10,000$0.00$0012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Stock Option (Right to Buy)derivativeindirect: See Footnotes
-10,000$0.00$0012 d ago
Sep 28, 2026Ra Capital Management, L.p.
director, owner
MOption exercise
Stock Option (Right to Buy)derivativeindirect: See Footnotes
-40,000$0.00$0012 d ago
Sep 15, 2026Stephen Basil Thomas
director
SOpen-market sale
Common Stock10b5-1
-100,000$13.67$1.4M467,96925 d ago
Aug 7, 2025Stephen Basil Thomas
director
AGrant or award
Common Stock
+100,375$0.00$0304,657Aug 11, 2025
Jun 27, 2025Aoife Brennan
President and CEO
MOption exercise
Common Stock10b5-1
+68,750--68,750Jul 1, 2025
Jun 27, 2025Stephen Basil Thomas
director
MOption exercise
Common Stock
+25,094--204,282Jul 1, 2025
Jun 30, 2025Aoife Brennan
President and CEO
SOpen-market sale
Common Stock10b5-1
-20,618$1.22$25k48,132Jul 1, 2025
Jun 27, 2025Stephen Basil Thomas
director
MOption exercise
Restricted Stock Unitsderivative
-25,094$0.00$00Jul 1, 2025
Jun 27, 2025Aoife Brennan
President and CEO
MOption exercise
Restricted Stock Unitsderivative10b5-1
-68,750$0.00$0206,250Jul 1, 2025
Jun 18, 2025Emily Pimblett
SVP, Finance & CAO
MOption exercise
Common Stock10b5-1
+5,000--20,130Jun 20, 2025
Jun 17, 2025Cindy Driscoll
Senior Vice President, Finance
AGrant or award
Stock Option (Right to Buy)derivative
+200,000$0.00$0200,000Jun 20, 2025
Jun 20, 2025Emily Pimblett
SVP, Finance & CAO
SOpen-market sale
Common Stock10b5-1
-1,242$1.24$1,54018,888Jun 20, 2025
Jun 18, 2025Emily Pimblett
SVP, Finance & CAO
MOption exercise
Restricted Stock Unitsderivative10b5-1
-5,000$0.00$015,000Jun 20, 2025
Jun 4, 2025Ra Capital Management, L.p.
director, owner
AGrant or award
Stock Option (Right to Buy)derivativeindirect: See Footnotes
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Kimberlee C Drapkin
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Alexander Cumbo
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Judith Dunn
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Andrew David Levin
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Stephen Basil Thomas
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Jun 4, 2025Douglas E Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,000$0.00$040,000Jun 5, 2025
Mar 31, 2025Douglas E Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+78,873$0.00$078,873Apr 1, 2025
Mar 28, 2025Alexander Cumbo
director
AGrant or award
Stock Option (Right to Buy)derivative
+80,000$0.00$080,000Apr 1, 2025
Mar 28, 2025Kimberlee C Drapkin
director
AGrant or award
Stock Option (Right to Buy)derivative
+80,000$0.00$080,000Apr 1, 2025
Mar 27, 2025Stephen Basil Thomas
director
MOption exercise
Common Stock
+25,093--179,188Mar 27, 2025
Mar 27, 2025Stephen Basil Thomas
director
MOption exercise
Restricted Stock Unitsderivative
-25,093$0.00$025,094Mar 27, 2025
Mar 18, 2025Emily Pimblett
SVP, Finance & CAO
MOption exercise
Common Stock10b5-1
+5,000--16,329Mar 20, 2025
Mar 20, 2025Emily Pimblett
SVP, Finance & CAO
SOpen-market sale
Common Stock10b5-1
-1,199$1.31$1,57115,130Mar 20, 2025
Mar 18, 2025Emily Pimblett
SVP, Finance & CAO
MOption exercise
Restricted Stock Unitsderivative10b5-1
-5,000$0.00$020,000Mar 20, 2025
Jan 13, 2025Aoife Brennan
President and CEO
AGrant or award
Stock Option (Right to Buy)derivative
+1,150,000$0.00$01,150,000Jan 15, 2025
Jan 13, 2025Brett Kaplan
Chief Operating Officer
AGrant or award
Stock Option (Right to Buy)derivative
+500,000$0.00$0500,000Jan 15, 2025
Jan 13, 2025Emily Pimblett
SVP, Finance and CAO
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Jan 15, 2025
Jan 1, 2025Stephen Basil Thomas
director
MOption exercise
Common Stock
+50,188--154,095Jan 3, 2025
Jan 1, 2025Stephen Basil Thomas
director
MOption exercise
Restricted Stock Unitsderivative
-50,188$0.00$050,187Jan 3, 2025
Dec 18, 2024Emily Pimblett
CHIEF ACCOUNTING OFFICER
MOption exercise
Common Stock10b5-1
+5,000--12,564Dec 20, 2024
Dec 19, 2024Emily Pimblett
CHIEF ACCOUNTING OFFICER
SOpen-market sale
Common Stock10b5-1
-1,235$2.02$2,49511,329Dec 20, 2024
Dec 18, 2024Emily Pimblett
CHIEF ACCOUNTING OFFICER
MOption exercise
Restricted Stock Unitsderivative10b5-1
-5,000$0.00$025,000Dec 20, 2024
Nov 11, 2024Douglas E Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+20,000$0.00$020,000Nov 12, 2024
Nov 11, 2024Douglas E Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+6,291$0.00$06,291Nov 12, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

CLYM insider trading: Climb Bio, Inc. | InsiderTell